Menu

SpyGlass Pharma, Inc. SGP

Full chart Compare
Set alert

Price alert · SGP

All alert types
34.31 USD +0.23 (+0.66%)

Nov 6, 2026, 10:41 AM EST

33.93 Day range 35.19
17.06 52-week range 35.75
YTD
+29.94%
1 year
+29.94%

Revenue & Expenses

Other Income → Gross Profit & Other Income: $1.53BGross Profit & Other Income → Net Income: $1.90BGross Profit & Other Income → Selling, General & Admin: $6.82BGross Profit & Other Income → Research & Development: $3.53BGross Profit & Other Income → Other Operating Expenses: $329.00MGross Profit & Other Income → Income Tax: $146.00MGross Profit → Gross Profit & Other Income: $11.20BRevenue → Gross Profit: $11.20BRevenue → Cost of Revenue: $7.31BOther Income$1.53BGross Profit$11.20BCost of Revenue$7.31BGross Profit & Other Income$12.73BNet Income$1.90BSelling, General & Admin$6.82BResearch & Development$3.53BOther Operating Expenses$329.00MIncome Tax$146.00MRevenue$18.50B

Latest period ending Dec 31, 2025 · select a line to chart its full history

SGP annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2008 Dec 31, 2008FY 2007 Dec 31, 2007
-41.45M-27.06M-14.23M514.00M-3.95B
-39.87M-29.16M-13.32M1.90B-1.47B
-17.98-16.31-1.341.07-1.04
SGP annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2008 Dec 31, 2008FY 2007 Dec 31, 2007
96.36M16.27M15.85M3.37B2.28B
115.87M23.32M41.15M28.12B29.16B
10.17M11.25M1.59M17.59B18.77B
1.58M3.90M08.18B9.48B
-98.84M-60.47M-32.99M10.53B10.38B
SGP annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2008 Dec 31, 2008FY 2007 Dec 31, 2007
-32.70M-22.03M-12.28M3.36B2.63B
-11.79M22.26M-20.49M-532.00M-13.16B
124.58M185.00K39.77M-1.66B10.09B
-789.00K-1.99M-216.54K-703.00M-616.00M
80.09M419.00K7.01M1.09B-387.00M